Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
Clinical trial NCT03733535 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03733535
- Sponsor
- Dr. Grace Parraga
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-03-20
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.